SWING IDEA - INFY

Price Action successfully retested recent swing low @ Support zone.
INFY is ready for its next leg up.
Expect at least 10% minimum from here.

Note

MACD Crossover is almost here. Once it crosses successfully, we can see the stock ready to rocket up.

Note

Positive News:

Infosys CEO Salil Parekh Settles Insider Trading Control Charges in India.
Also MACD Crossover has just happened successfully. We can expect the stock to Rally further from here.

Note

We are very close to our Targets now. Just a few more points left. Also MACD has made a beautiful crossover. Ideally next week should take the stock more up. Keep holding guys.

Note

Positive News:
Infosys' Business Process Management Arm Opens New Office in Puerto Rico

Trade fermée: cible de profit atteinte

Trade Completed. Target Achieved.
Total 16% Profits booked.
Time Taken = 7 weeks.

Congrats to those who made good profits with this Trade.
This is how perfectly Price Action can mint you money when done right.

Trade can still be held on based on your Risk Management as the momentum still looks strong and it is possible that the Stock can go further upward.

Follow for more such Ideas!
Comment any Stock that you want me to take a look into and share insights.

Kudos!!

Note

Close to 19% Profits from our Entry Zone. Congrats to those who are still holding on to this stock and booking higher profits.

Note

Close to 28% Profits from our Entry Zone. Congrats to those who are still holding on to this stock and booking higher profits.

Note

31% Profits from our Entry Zone. Congrats to those who are still holding on to this stock and booking higher profits.

Trade fermée: cible de profit atteinte

Achieved 35% Profits from our Entry Zone. Congrats to those who are still holding on to this trade and booking higher profits.

Trade fermée: cible de profit atteinte

Achieved 38% from our Entry Zone. Congrats to those who still held on to this trade and booked even more higher profits.

thepranam

Aussi sur:

Clause de non-responsabilité

Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.

thepranam

Aussi sur: